ID

27425

Descripción

A Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (0646-007); ODM derived from: https://clinicaltrials.gov/show/NCT00654420

Link

https://clinicaltrials.gov/show/NCT00654420

Palabras clave

Versiones (1)
  1. 14/11/17 14/11/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

14 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non-small-cell Lung NCT00654420

Inglés

Eligibility Carcinoma, Non-small-cell Lung NCT00654420

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject has locally advanced or metastatic stage iiib/iv non-small cell lung cancer that has relapsed after chemotherapy/chemoratiotherapy.
Descripción

Non-Small Cell Lung Carcinoma Advanced Local TNM clinical staging | Non-small cell lung cancer metastatic TNM clinical staging | Chemotherapy | Chemoradiotherapy | Recurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205276
UMLS CUI [1,4]
C3258246
UMLS CUI [2,1]
C0278987
UMLS CUI [2,2]
C3258246
UMLS CUI [3]
C0392920
UMLS CUI [4]
C0436307
UMLS CUI [5]
C0277556
subject has had at least one chemotherapy regimen for recurrent or metastatic disease.
Descripción

Chemotherapy Quantity Recurrent disease | Chemotherapy Quantity Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0277556
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0027627
subject is 18 years of age or older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
subject has a performance status of 0-2 on ecog scale.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
women of childbearing potential have a negative pregnancy test
Descripción

Childbearing Potential Pregnancy test negative

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject has had chemotherapy within 2 weeks or biological therapy (e.g. bevacizumab) within 4 weeks
Descripción

Chemotherapy | Biological treatment | bevacizumab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1531518
UMLS CUI [3]
C0796392
subject has not recovered from adverse events from previous therapy within 4 weeks
Descripción

Adverse event Due to Prior Therapy | Recovery Lacking

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332268
subject has received egfr-tki inhibitor/anti-egfr mab therapy
Descripción

EGFR-TK inhibitor | Anti-EGFR Antibody

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1443775
UMLS CUI [2]
C4055105
subject has received igf1r-tki inhibitor/anti-igf1r mab therapy
Descripción

IGF1R | Other Coding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0140080
UMLS CUI [2]
C3846158
subject has had more than 2 systemic chemotherapies for metastatic disease
Descripción

Systemic Chemotherapy Quantity Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1883256
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
subject has not completed radiotherapy with complete resolution of toxicities at least 2 weeks before starting in the study
Descripción

Therapeutic radiology procedure Completion Lacking | Toxicity Resolution Lacking

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0205197
UMLS CUI [1,3]
C0332268
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C1514893
UMLS CUI [2,3]
C0332268
subject is taking part in another clinical study
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
subject has a primary central nervous system tumor
Descripción

Central Nervous System Neoplasms, Primary

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751620
subject abuses drugs or alcohol
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
subject is pregnant or breastfeeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
subject is hiv positive
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
subject has a history of hepatitis b or c
Descripción

Hepatitis B | Hepatitis C

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
subject is using growth hormone or growth hormone inhibitors
Descripción

Growth Hormone | Growth Hormone Receptor Inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0037663
UMLS CUI [2]
C3812146
Volver a la parte superior de la página

Similar models

Eligibility Carcinoma, Non-small-cell Lung NCT00654420

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced Local TNM clinical staging | Non-small cell lung cancer metastatic TNM clinical staging | Chemotherapy | Chemoradiotherapy | Recurrent disease
Item
subject has locally advanced or metastatic stage iiib/iv non-small cell lung cancer that has relapsed after chemotherapy/chemoratiotherapy.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
C0278987 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C0436307 (UMLS CUI [4])
C0277556 (UMLS CUI [5])
Chemotherapy Quantity Recurrent disease | Chemotherapy Quantity Neoplasm Metastasis
Item
subject has had at least one chemotherapy regimen for recurrent or metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
Age
Item
subject is 18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
subject has a performance status of 0-2 on ecog scale.
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative
Item
women of childbearing potential have a negative pregnancy test
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy | Biological treatment | bevacizumab
Item
subject has had chemotherapy within 2 weeks or biological therapy (e.g. bevacizumab) within 4 weeks
boolean
C0392920 (UMLS CUI [1])
C1531518 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
Adverse event Due to Prior Therapy | Recovery Lacking
Item
subject has not recovered from adverse events from previous therapy within 4 weeks
boolean
C0877248 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
EGFR-TK inhibitor | Anti-EGFR Antibody
Item
subject has received egfr-tki inhibitor/anti-egfr mab therapy
boolean
C1443775 (UMLS CUI [1])
C4055105 (UMLS CUI [2])
IGF1R | Other Coding
Item
subject has received igf1r-tki inhibitor/anti-igf1r mab therapy
boolean
C0140080 (UMLS CUI [1])
C3846158 (UMLS CUI [2])
Systemic Chemotherapy Quantity Neoplasm Metastasis
Item
subject has had more than 2 systemic chemotherapies for metastatic disease
boolean
C1883256 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Therapeutic radiology procedure Completion Lacking | Toxicity Resolution Lacking
Item
subject has not completed radiotherapy with complete resolution of toxicities at least 2 weeks before starting in the study
boolean
C1522449 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0600688 (UMLS CUI [2,1])
C1514893 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Study Subject Participation Status
Item
subject is taking part in another clinical study
boolean
C2348568 (UMLS CUI [1])
Central Nervous System Neoplasms, Primary
Item
subject has a primary central nervous system tumor
boolean
C0751620 (UMLS CUI [1])
Substance Use Disorders
Item
subject abuses drugs or alcohol
boolean
C0038586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
subject is pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
subject is hiv positive
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
subject has a history of hepatitis b or c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Growth Hormone | Growth Hormone Receptor Inhibitor
Item
subject is using growth hormone or growth hormone inhibitors
boolean
C0037663 (UMLS CUI [1])
C3812146 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial